Dr. Carl Regillo, Chief of the Retina Service at Wills Eye Hospital, contributed to this Modern Retina article on the revolutionary impact of gene therapy on retinal disease treatment:

Join us in congratulating Mak Djulbegovic, MD!

Dr. Djulbegovic has been honored with a prestigious research award from the VitreoRetinal Surgery Foundation for his work on identifying protein targets for proliferative vitreoretinopathy (PVR).

This week at Wills Eye!

Register for these continuing medical education opportunities: https://www.willseye.org/education-events-calendar/

Sign up for regular emails about CME at Wills Eye: https://www.willseye.org/webinar